Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9615 posts found.

pfizer_brussels

Pfizer’s Remicade biosimilar displays similar efficacy

February 22, 2017 Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …
News

Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
Feature
roche__tree

Roche and Discuva extend agreement to develop target antimicrobials

February 22, 2017 Research and Development, Sales and Marketing Discuva, Roche

Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
News
8224204466_e6b23e80e6_z

Rabbit virus proves effective in treatment of multiple myeloma

February 22, 2017 Research and Development multiple myeloma

A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …
News
old_man_stick

Testosterone gel trials reveal mixed results of benefits and drawbacks

February 22, 2017 Research and Development Testosterone gel, testosterone

A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …
News
headshot_ryan

Nativis bolsters boardroom with new director

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
Appointment
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …
News

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017 Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
News
naloxone

FDA rejects Amphastar’s application for NDA for intranasal overdose treatment

February 21, 2017 Research and Development Amphastar, FDA

Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
News
aging_-_hand

Anti-aging study reveals role of mitochondria pointing towards new medicine

February 21, 2017 Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria

A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
News

BlackThorn Therapeutics bring in new CEO

February 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Appointment
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017 Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
News
novartis_appointment

New Managing Director of UK & Ireland for Novartis

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
News
astrazeneca_logo_building

AstraZeneca’s drug scores positive results against chemo in breast cancer

February 17, 2017 Medical Communications, Research and Development AstraZeneca

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …
News
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026